Hypovolemic Shock
17
2
2
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.9%
1 terminated out of 17 trials
90.9%
+4.4% vs benchmark
24%
4 trials in Phase 3/4
10%
1 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (17)
Digital Escape Room Game for Hypovolemic Shock Management
A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients
Efficacy of Prehospital Tourniquet Models for Arterial Occlusion in Upper and Lower Limbs
A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent
Early Initiated Vasopressor Therapy in the Emergency Department
Digital Ischemia Reduction in Critically Ill Patients
Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock
PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock
Evaluation of Resuscitation Markers in Trauma Patients
Inferior Vena Cava Assessment in Term Pregnancy Using Ultrasound: a Feasibility Study of Subxiphoid and RUQ Views
Kinetics of the Sublingual Microcirculation During Fluid Bolus
Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of Hemolysis
Impact of Early Goal-directed Fluid Therapy in Hypovolemic Patients Undergoing Emergency Surgery
Renal Resistive Index in Patients With Shock
Non-Pneumatic Anti-Shock Garment for Obstetrical Hemorrhage: Zambia and Zimbabwe
Hemodynamic Measurements at Different Inclinations of the Head
Efficacy Study of the Non-Pneumatic Anti-Shock Garment (NASG) in Egypt